Clinical potential of epigenetic and microRNA biomarkers in PTSD
Open Access
- 2 July 2024
- journal article
- review article
- Published by Taylor & Francis in Journal of Neurogenetics
- Vol. 38 (3) , 79-101
Abstract
Molecular studies identifying alterations associated with PTSD have predominantly focused on candidate genes or conducted genome-wide analyses, often encountering issues with replicability. This review aims to identify robust bi-directional epigenetic and microRNA (miRNA) regulators focusing on their functional impacts on post-traumatic stress disorder (PTSD) and their utility in clinical diagnosis, whilst examining knowledge gaps in the existing research. A systematic search was conducted across multiple databases, including Web of Science, Scopus, Global Health (CABI), and PubMed, augmented by grey literature, yielding 3465 potential articles. Ultimately, 92 studies met the inclusion criteria and were analysed to pinpoint significant epigenetic changes with clinically relevant potential in PTSD. The selected studies explored histone modifications, CpG sites, single nucleotide polymorphisms (SNPs), and miRNA biomarkers. Specifically, nine studies examined epigenetic markers, detailing the influence of methylation on chromatin accessibility at histone positions H3K4, H3K9, and H3K36 within a PTSD context. Seventy-three studies investigated DNA methylation, identifying 20 hypermethylated and five hypomethylated CpG islands consistently observed in PTSD participants. Nineteen studies linked 88 SNPs to PTSD, with only one SNP replicated within these studies. Furthermore, sixteen studies focused on miRNAs, with findings indicating 194 downregulated and 24 upregulated miRNAs were associated with PTSD. Although there are epigenetic mechanisms that are significantly affected by PTSD, a granular deconstruction of these mechanisms elucidates the need to incorporate more nuanced approaches to identifying the factors that contribute to PTSD. Technological advances in diagnostic tools are driving the need to integrate detailed participant characteristics, trauma type, genetic susceptibilities, and best practices for robust reporting. This comprehensive approach will be crucial for enhancing the translational potential of PTSD research for clinical application.Keywords
This publication has 147 references indexed in Scilit:
- Methylation of theAIM2gene: An epigenetic mediator of PTSD‐related inflammation and neuropathology plasma biomarkersDepression and Anxiety, 2022
- Epigenome‐Wide Study of Posttraumatic Stress Disorder Symptom Severity in a Treatment‐Seeking Adolescent SampleJournal of Traumatic Stress, 2021
- Genetic risk mechanisms of posttraumatic stress disorder in the human brainJournal of Neuroscience Research, 2016
- EPIGENETIC VARIATION AT SKA2 PREDICTS SUICIDE PHENOTYPES AND INTERNALIZING PSYCHOPATHOLOGYDepression and Anxiety, 2016
- A genome‐wide identified risk variant for PTSD is a methylation quantitative trait locus and confers decreased cortical activation to fearful facesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2015
- MicroRNA degradation and turnover: regulating the regulatorsWIREs RNA, 2012
- Common Heritable Contributions to Low-Risk Trauma, High-Risk Trauma, Posttraumatic Stress Disorder, and Major DepressionArchives of General Psychiatry, 2012
- Differential immune system DNA methylation and cytokine regulation in post‐traumatic stress disorderAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2011
- SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorderDepression and Anxiety, 2011
- A Twin Study of Genetic and Environmental Contributions to Liability for Posttraumatic Stress SymptomsArchives of General Psychiatry, 1993